Abstract:Microglia are dynamic immunosurveillance cells in the CNS. Whether microglia are protective or pathologic is context dependent; the outcome varies as a function of time relative to the stimulus, activation state of neighboring cells in the microenvironment or within progression of a particular disease. Although brain microglia can be "primed" using bacterial lipopolysaccharide (LPS)/endotoxin, it is unknown whether LPS delivered systemically can also induce neuroprotective microglia in the spinal cord. Here, we show that serial systemic injections of LPS (1 mg/kg, i.p., daily) for 4 consecutive days (LPSx4) consistently elicit a reactive spinal cord microglia response marked by dramatic morphologic changes, increased production of IL-1, and enhanced proliferation without triggering leukocyte recruitment or overt neuropathology. Following LPSx4, reactive microglia frequently contact spinal cord endothelial cells. Targeted ablation or selective expression of IL-1 and IL-1 receptor (IL-1R) in either microglia or endothelia reveal that IL-1-dependent signaling between these cells mediates microglia activation. Using a mouse model of ischemic spinal cord injury in male and female mice, we show that preoperative LPSx4 provides complete protection from ischemia-induced neuron loss and hindlimb paralysis. Neuroprotection is partly reversed by either pharmacological elimination of microglia or selective removal of IL-1R in microglia or endothelia. These data indicate that spinal cord microglia are amenable to therapeutic reprogramming via systemic manipulation and that this potential can be harnessed to protect the spinal cord from injury.SIGNIFICANCE STATEMENT Data in this report indicate that a neuroprotective spinal cord microglia response can be triggered by daily systemic injections of LPS over a period of 4 d (LPSx4). The LPSx4 regimen induces morphologic transformation and enhances proliferation of spinal cord microglia without causing neuropathology. Using advanced transgenic mouse technology, we show that IL-1-dependent microglia-endothelia cross talk is necessary for eliciting this spinal cord microglia phenotype and also for conferring optimal protection to spinal motor neurons from ischemic spinal cord injury (ISCI). Collectively, these novel data show that it is possible to consistently elicit spinal cord microglia via systemic delivery of inflammogens to achieve a therapeutically effective neuroprotective response against ISCI.

NO mediates microglial response to acute spinal cord injury under ATP control in vivo

The Role of Purinergic Receptors in Neural Repair and Regeneration after Spinal Cord Injury

Spinal Microglial Motility is Independent of Neuronal Activity and Plasticity in Adult Mice

ERK1/2 and P38 Mitogen-Activated Protein Kinase Mediate Inos-Induced Spinal Neuron Degeneration after Acute Traumatic Spinal Cord Injury.

Microglial-Mediated Prevention of Axonal Degeneration in the Injured Spinal Cord: Insights from an Imaging Study

Current Knowledge of Microglia in Traumatic Spinal Cord Injury

The Role of Microglia in Neuroinflammation of the Spinal Cord after Peripheral Nerve Injury

Single-cell sequencing reveals microglia induced angiogenesis by specific subsets of endothelial cells following spinal cord injury

Microglia coordinate cellular interactions during spinal cord repair in mice

The toll-like receptor 2 agonist Pam3CSK4 is neuroprotective after spinal cord injury

Mitigation of Microglia-mediated Acute Neuroinflammation and Tissue Damage by Heme Oxygenase 1 in a Rat Spinal Cord Injury Model

Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury

Glial Nitric Oxide-Mediated Long-Term Presynaptic Facilitation Revealed by Optical Imaging in Rat Spinal Dorsal Horn

In vivo imaging in mouse spinal cord reveals that microglia prevent degeneration of injured axons

Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury

Spatiotemporally selective ATP events from astrocytes encode injury information and guide sustained microglial response

Inflammatory Cytokine Profile and Plasticity of Brain and Spinal Microglia in Response to ATP and Glutamate

Microglial Activation in the Motor Cortex Mediated NLRP3-related Neuroinflammation and Neuronal Damage Following Spinal Cord Injury

A Critical Role for Microglia in Regulating Metabolic Homeostasis and Neural Repair after Spinal Cord Injury

Microglia: a promising therapeutic target in spinal cord injury

Serial Systemic Injections of Endotoxin (LPS) Elicit Neuroprotective Spinal Cord Microglia through IL-1-Dependent Cross Talk with Endothelial Cells